StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > it's not over just a start

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon Jul 05, 2021 5:55pm

120 Views

Post# 33496685

RE:RE:RE:it's not over just a start

Going to need something good.

Tough thinking about the fact there is still another 6 weeks until we get Q2 info and really Im not expecting much of anything and then waiting another 3 months after that for Q3.

I dont see how this SP stays above 40 cents until Q3 and if they dont have something by then it will be trying to hold onto 30s by Q4.

<< Previous

Bullboard Posts

Next >>

Geologica Resource: Polymetallic upside at a depressed price